- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Park expands global sales network
Digital gamma camera developer Park Medical Systems is in theprocess of making several corporate-level moves designed to streamlinethe company's operations. Park has added to its global sales force, hiring sales reps tocover South Korea, China, Italy,
Digital gamma camera developer Park Medical Systems is in theprocess of making several corporate-level moves designed to streamlinethe company's operations.
Park has added to its global sales force, hiring sales reps tocover South Korea, China, Italy, the United Arab Emirates, Qatarand Austria. It has also restructured its North American offices,moving its U.S. office from Boston to Orlando and moving the officesof Toronto-based parent Park Meditech to those of Park Medicalin Montreal.
Park this month signed a sales and marketing agreement with cyclotrondeveloper CTI of Nashville, according to Richard Mullen, presidentand CEO of Park Medical and Park Meditech. CTI hopes that theuse of Park cameras in high-energy imaging will increase salesof fluorodeoxyglucose (FDG) manufactured in its cyclotrons.
New enhancements to Park's line of Smart digital cameras includeremote diagnostics, a learning mode for gantry motion, a scintimammographypositioning device and a new half-inch crystal option for high-energyimaging. Park will also show works-in-progress developments initerative reconstruction on Sun Microsystems' new Ultra 2 workstation.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
